Eva Kempers &
Marieke J.H.A. Kruip/LinkedIn
Aug 17, 2025, 08:21
Eva Kempers: Menstrual Blood Loss and Quality of Life in Antiplatelet Therapy
Research and Practice in Thrombosis and Haemostasis (RPTH) shared a study by Eva Kempers, Postdoctoral researcher at the University of Antwerp, on LinkedIn :
“This study from Eva Kempers and team examined menstrual blood loss and related quality of life among women on antiplatelet therapy and a control group.
Their data reveal that both outcomes were comparable, great news for women who need antiplatelet therapy.”
Read the full article here.
Article: Menstrual bleeding-specific quality of life in women on antiplatelet therapy
Authors: Eva K. Kempers, Johanna A. van der Zande, Paula M. Janssen, Jérôme M.J. Cornette, Jolien W. Roos–Hesselink
Senior author: Marieke J.H.A. Kruip
Find the newest developments in clotting science in Hemostasis Today.
Antiplatelet Therapy
Eva Kempers
Health
Hematology
Hemostasis Today
Jérôme M.J. Cornette
Johanna A. van der Zande
Jolien W. Roos–Hesselink
Marieke J.H.A. Kruip
Medicine
menstrual bleeding
menstrual blood loss
Paula M. Janssen
Research and Practice in Thrombosis and Haemostasis
RPTH Journal
University of Antwerp
-
Aug 17, 2025, 12:18Omar Adwan on G6PD Deficiency: Protecting Red Blood Cells from Oxidative Stress
-
Aug 17, 2025, 08:00Eddy Gutierrez Shares Insights on Thrombocytopenia Management in the ICU
-
Aug 17, 2025, 07:14National Research Blueprint Evolves into Bleeding Disorders Research Collaborative
-
Aug 16, 2025, 17:35Join the Genicular Artery Embolization (GAE) Summit!
-
Aug 16, 2025, 14:00Iron Deficiency in Polycythemia Vera: William Aird Reveals JAK2-Driven Erythropoiesis as The Key Cause
-
Aug 17, 2025, 11:34DAPT After PCI: Sex-Specific Strategies Unveiled
-
Aug 17, 2025, 08:21Eva Kempers: Menstrual Blood Loss and Quality of Life in Antiplatelet Therapy
-
Aug 17, 2025, 07:44CDC/FDA Data Shows 112,000% More Brain Clots After mRNA Shots
-
Aug 16, 2025, 16:33RPTH Journal: Dietmar Fries and Colleagues Explore Impact of Long-Distance Trail Running on Blood Markers
-
Aug 16, 2025, 16:15Josepha Clara Sedzro: First Cryo-EM Structure of the Coagulation Initiation Complex
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 15, 2025, 03:44Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
Aug 17, 2025, 11:34
Aug 17, 2025, 08:21
Aug 17, 2025, 08:00
Aug 17, 2025, 07:44
Aug 16, 2025, 17:35
Aug 16, 2025, 16:50